Synthesis of isotopically labeled CIS-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro-3-(N-propyl)-1H-benz[e]indole-9-carboxamide, a 5-HT1A receptor agonist
The title compound is a potent and selective 5‐HT1A receptor agonist with clinical potentials for treating anxiety and depression. It has been labeled with stable and radioactive isotopes to support ADME studies in animals and human subjects. Its carboxamide group was labeled with C‐14, C‐13, or C‐1...
Saved in:
Published in | Journal of labelled compounds & radiopharmaceuticals Vol. 39; no. 11; pp. 891 - 900 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester
John Wiley & Sons, Ltd
01.11.1997
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The title compound is a potent and selective 5‐HT1A receptor agonist with clinical potentials for treating anxiety and depression. It has been labeled with stable and radioactive isotopes to support ADME studies in animals and human subjects. Its carboxamide group was labeled with C‐14, C‐13, or C‐13, N‐15, and O‐18. To provide a radioligand for investigating the receptor binding characteristics of the compound, we also labeled it with tritium in the N‐propyl group to obtain the high specific activity of 86.7 Ci/mmol. © 1997 John Wiley & Sons, Ltd. |
---|---|
Bibliography: | ark:/67375/WNG-ZPMJFWX5-H ArticleID:JLCR34 istex:56B3AB4DD59FDC4B9B5856064C555039544764D4 |
ISSN: | 0362-4803 1099-1344 |
DOI: | 10.1002/(SICI)1099-1344(199711)39:11<891::AID-JLCR34>3.0.CO;2-Q |